Bio Historical Income Statement

BIO Stock  USD 349.56  9.04  2.65%   
Historical analysis of Bio Rad income statement accounts such as Interest Expense of 51.9 M, Selling General Administrative of 481.6 M or Total Revenue of 1.4 B can show how well Bio Rad Laboratories performed in making a profits. Evaluating Bio Rad income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Bio Rad's future profits or losses.
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Bio-Rad Laboratories latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Bio-Rad Laboratories is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bio Rad Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.

About Bio Income Statement Analysis

Bio-Rad Laboratories Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Bio Rad shareholders. The income statement also shows Bio investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Bio Rad Income Statement Chart

Bio Rad Laboratories Income Statement is one of the three primary financial statements used for reporting Bio's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Bio-Rad Laboratories revenue and expense. Bio Rad Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Bio Rad's Non Operating Income Net Other is very stable compared to the past year. As of the 28th of March 2024, Non Recurring is likely to grow to about 353.2 M, while Selling General Administrative is likely to drop about 481.6 M.

Total Revenue

Total revenue comprises all receipts Bio-Rad Laboratories generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Bio Rad Laboratories minus its cost of goods sold. It is profit before Bio Rad operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Bio-Rad Laboratories. It is also known as Bio Rad overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.
Most accounts from Bio Rad's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Bio-Rad Laboratories current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bio Rad Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
At this time, Bio Rad's Non Operating Income Net Other is very stable compared to the past year. As of the 28th of March 2024, Non Recurring is likely to grow to about 353.2 M, while Selling General Administrative is likely to drop about 481.6 M.
 2021 2022 2023 2024 (projected)
Gross Profit1.6B1.6B1.4B769.3M
Total Revenue2.9B2.8B2.7B1.4B

Bio Rad income statement Correlations

0.450.730.750.750.750.580.70.820.970.73-0.04-0.09-0.04-0.060.78-0.88-0.030.610.57-0.010.160.53-0.51-0.58-0.45
0.450.190.180.180.180.260.260.330.360.18-0.45-0.46-0.45-0.450.18-0.43-0.440.350.04-0.42-0.420.41-0.090.0-0.41
0.730.190.950.940.990.240.410.520.771.00.160.130.160.150.93-0.90.120.120.20.130.22-0.040.06-0.260.22
0.750.180.951.00.990.480.650.710.820.960.170.140.180.170.95-0.830.150.30.380.150.380.05-0.04-0.430.17
0.750.180.941.00.980.510.670.730.820.950.190.150.190.180.95-0.830.160.290.370.170.410.03-0.05-0.420.18
0.750.180.990.990.980.370.540.630.810.990.160.130.160.150.96-0.870.130.220.30.140.30.020.01-0.350.2
0.580.260.240.480.510.370.880.850.60.280.10.050.110.080.46-0.350.130.540.530.120.50.38-0.46-0.52-0.35
0.70.260.410.650.670.540.880.980.780.440.120.050.120.10.58-0.510.140.740.740.140.540.43-0.58-0.74-0.35
0.820.330.520.710.730.630.850.980.880.540.080.020.090.070.67-0.630.10.750.740.110.470.48-0.6-0.74-0.4
0.970.360.770.820.820.810.60.780.880.780.070.020.070.050.83-0.890.070.610.620.090.290.46-0.53-0.63-0.37
0.730.181.00.960.950.990.280.440.540.780.160.130.160.150.95-0.90.120.110.190.130.25-0.050.06-0.250.23
-0.04-0.450.160.170.190.160.10.120.080.070.161.01.01.00.13-0.061.0-0.230.140.990.79-0.45-0.09-0.150.22
-0.09-0.460.130.140.150.130.050.050.020.020.131.01.01.00.1-0.030.99-0.280.090.990.76-0.48-0.05-0.10.24
-0.04-0.450.160.180.190.160.110.120.090.070.161.01.01.00.14-0.061.0-0.230.140.990.8-0.44-0.09-0.160.21
-0.06-0.450.150.170.180.150.080.10.070.050.151.01.01.00.12-0.060.99-0.240.130.990.78-0.46-0.08-0.140.23
0.780.180.930.950.950.960.460.580.670.830.950.130.10.140.12-0.870.10.190.230.10.340.03-0.04-0.290.14
-0.88-0.43-0.9-0.83-0.83-0.87-0.35-0.51-0.63-0.89-0.9-0.06-0.03-0.06-0.06-0.87-0.04-0.27-0.25-0.06-0.12-0.160.20.270.11
-0.03-0.440.120.150.160.130.130.140.10.070.121.00.991.00.990.1-0.04-0.180.181.00.8-0.38-0.13-0.190.13
0.610.350.120.30.290.220.540.740.750.610.11-0.23-0.28-0.23-0.240.19-0.27-0.180.88-0.160.070.83-0.73-0.86-0.69
0.570.040.20.380.370.30.530.740.740.620.190.140.090.140.130.23-0.250.180.880.20.380.62-0.78-0.99-0.51
-0.01-0.420.130.150.170.140.120.140.110.090.130.990.990.990.990.1-0.061.0-0.160.20.79-0.36-0.15-0.210.12
0.16-0.420.220.380.410.30.50.540.470.290.250.790.760.80.780.34-0.120.80.070.380.79-0.27-0.24-0.40.13
0.530.41-0.040.050.030.020.380.430.480.46-0.05-0.45-0.48-0.44-0.460.03-0.16-0.380.830.62-0.36-0.27-0.62-0.6-0.85
-0.51-0.090.06-0.04-0.050.01-0.46-0.58-0.6-0.530.06-0.09-0.05-0.09-0.08-0.040.2-0.13-0.73-0.78-0.15-0.24-0.620.730.72
-0.580.0-0.26-0.43-0.42-0.35-0.52-0.74-0.74-0.63-0.25-0.15-0.1-0.16-0.14-0.290.27-0.19-0.86-0.99-0.21-0.4-0.60.730.45
-0.45-0.410.220.170.180.2-0.35-0.35-0.4-0.370.230.220.240.210.230.140.110.13-0.69-0.510.120.13-0.850.720.45
Click cells to compare fundamentals

Bio Rad Account Relationship Matchups

Bio Rad income statement Accounts

201920202021202220232024 (projected)
Depreciation And Amortization160.3M162.6M160.6M181.9M192.4M202.0M
Interest Expense23.4M21.9M1.6M38.1M49.4M51.9M
Selling General Administrative824.6M800.3M879.6M827.8M846.8M481.6M
Total Revenue2.3B2.5B2.9B2.8B2.7B1.4B
Gross Profit1.3B1.4B1.6B1.6B1.4B769.3M
Other Operating Expenses2.1B2.1B2.4B2.3B2.3B1.2B
Operating Income229.7M411.0M489.4M482.6M383.8M403.0M
Ebit229.7M411.0M489.4M482.6M383.8M403.0M
Ebitda390.0M573.6M650.0M664.5M576.2M605.0M
Cost Of Revenue1.1B1.1B1.3B1.2B1.2B1.3B
Total Operating Expenses1.0B1.0B1.2B1.1B1.0B613.7M
Income Before Tax2.3B4.9B5.4B(4.7B)(850.1M)(807.6M)
Total Other Income Expense Net2.0B4.5B4.9B(5.2B)(1.2B)(1.2B)
Net Income1.8B3.8B4.3B(3.6B)(637.3M)(605.5M)
Income Tax Expense502.4M1.1B1.2B(1.1B)(212.8M)(202.1M)
Research Development202.7M226.6M271.7M256.9M226.9M161.8M
Net Income Applicable To Common Shares1.8B3.8B4.2B(3.6B)(4.2B)(4.0B)
Net Income From Continuing Ops1.8B3.8B4.2B(3.6B)(159.3M)(151.3M)
Non Operating Income Net Other23.8M22.7M24.0M44.8M51.5M54.1M
Tax Provision502.4M1.1B1.2B(1.1B)(27.9M)(26.5M)
Interest Income30.5M4.5B4.9B58M96.4M91.6M
Net Interest Income7.1M(21.9M)(1.6M)19.9M47.6M50.0M

Pair Trading with Bio Rad

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bio Rad position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Rad will appreciate offsetting losses from the drop in the long position's value.

Moving together with Bio Stock

  0.81EQ Equillium Financial Report 9th of May 2024 PairCorr

Moving against Bio Stock

  0.69MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr
  0.65KA Kineta Inc Report 29th of March 2024 PairCorr
  0.63MEIP MEI Pharma Financial Report 9th of May 2024 PairCorr
  0.62VALN Valneva SE ADR Financial Report 2nd of May 2024 PairCorr
  0.58MBIO Mustang Bio Report 3rd of April 2024 PairCorr
The ability to find closely correlated positions to Bio Rad could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bio Rad when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bio Rad - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bio Rad Laboratories to buy it.
The correlation of Bio Rad is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bio Rad moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bio-Rad Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bio Rad can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Bio-Rad Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Rad's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Rad Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Rad Laboratories Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bio Rad Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Complementary Tools for Bio Stock analysis

When running Bio Rad's price analysis, check to measure Bio Rad's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Rad is operating at the current time. Most of Bio Rad's value examination focuses on studying past and present price action to predict the probability of Bio Rad's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Rad's price. Additionally, you may evaluate how the addition of Bio Rad to your portfolios can decrease your overall portfolio volatility.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Commodity Directory
Find actively traded commodities issued by global exchanges
Stocks Directory
Find actively traded stocks across global markets
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Is Bio Rad's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Rad. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Rad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.56)
Earnings Share
(21.83)
Revenue Per Share
91.453
Quarterly Revenue Growth
(0.07)
Return On Assets
0.0177
The market value of Bio-Rad Laboratories is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Rad's value that differs from its market value or its book value, called intrinsic value, which is Bio Rad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Rad's market value can be influenced by many factors that don't directly affect Bio Rad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bio Rad's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Rad is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Rad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.